Wellington Management Group LLP Agenus Inc Transaction History

Wellington Management Group LLP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$0.53 - $0.93 $1.22 Million - $2.14 Million	2,297,397 New	2,297,397 $1.33 Million
Q1 2023 May 12, 2023	SELL	$1.45 - $2.95 $48,360 - $98,388	-33,352 Reduced 7.05%	439,558 $668,000
Q4 2022 Feb 13, 2023	BUY	$2.02 - $3.25 $78,913 - $126,964	39,066 Added 9.0%	472,910 $1.13 Million
Q3 2022 Nov 14, 2022	SELL	$1.96 - $3.14 $178,973 - $286,722	-91,313 Reduced 17.39%	433,844 $889,000
Q1 2022 May 16, 2022	BUY	$2.35 - $3.47 $7,567 - $11,173	3,220 Added 0.62%	525,157 $1.29 Million
Q4 2021 Feb 11, 2022	BUY	$2.92 - $5.74 $1.52 Million - $3 Million	521,937 New	521,937 $1.68 Million

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

Stay updated on Wellington Management Group LLP with notifications on news.